Sanofi (SNY) Accumulated Expenses (2019 - 2024)

Sanofi has disclosed Accumulated Expenses across 6 years of filings, most recently posting $91.9 million for Q4 2024.

• In Q4 2024, Accumulated Expenses fell 76.92% year-over-year to $91.9 million; the TTM figure through Dec 2024 stood at $91.9 million (down 76.92% YoY), while the FY2024 annual figure was $93.1 million, down 76.74% from the prior year.
• Accumulated Expenses came in at $91.9 million for Q4 2024 at Sanofi, down from $398.1 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $889.4 million in Q4 2020 to a low of -$819.3 million in Q4 2022.
• Average Accumulated Expenses over 5 years is $80.1 million, with a median of $80.3 million recorded in 2024.
• Year-over-year, Accumulated Expenses surged 2769.85% in 2020 and plunged 1293.59% in 2022.
• Over 5 years, Accumulated Expenses stood at $889.4 million in 2020, then sank by 92.28% to $68.6 million in 2021, then tumbled by 1293.59% to -$819.3 million in 2022, then soared by 148.59% to $398.1 million in 2023, then slumped by 76.92% to $91.9 million in 2024.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $91.9 million in Q4 2024, $398.1 million in Q4 2023, and -$819.3 million in Q4 2022.